ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,033.11
0.94%
US Tech 100
21,244.80
-0.59%
Dow Jones
42,515.09
0.75%
Brent Oil
73.61
2.58%
Bitcoin
106,159.47
-0.55%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. AtriCure Inc (ATRC) Quote

AtriCure Inc

AtriCure Inc (ATRC)

NASDAQ
32.31
0.69
(2.18%)
Closed June 16 4:00PM
15 min delayed - Upgrade to Realtime
32.31
0.00
( 0.00% )
Pre Market: 5:28AM
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
32.31
Bid
30.97
Ask
33.14
Volume
-
0.00 Day's Range 0.00
18.94 52 Week Range 43.11
Market Cap
1.6B
Previous Close
32.31
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
595,152
Shares Outstanding
49,504,851
Dividend Yield
-
PE Ratio
-35.78
Earnings Per Share (EPS)
-0.9
Revenue
465.31M
Net Profit
-44.7M

About AtriCure Inc

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft T... AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.atricure.com
Headquarters
Wilmington, Delaware, USA
Founded
-
AtriCure Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker ATRC. The last closing price for AtriCure was $32.31. Over the last year, AtriCure shares have traded in a share price range of $ 18.94 to $ 43.11.

AtriCure currently has 49,504,851 shares outstanding. The market capitalization of AtriCure is $1.60 billion. AtriCure has a price to earnings ratio (PE ratio) of -35.78.

Ask ADVFN Intelligence (AI)

ATRC Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 30 2025
ATRC (2.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 07 2025
ATRC (2.18%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
April 30 2025
ATRC (2.18%)

Form 8-K - Current report
Edgar (US Regulatory)
April 29 2025
ATRC (2.18%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.9-5.5539315989534.2134.4931.4739557332.51991971CS
4-0.02-0.061862047633832.3335.3331.4747673433.73087821CS
12-2.74-7.8174037089935.0535.6328.2959515232.27329237CS
260.642.0208399115931.6743.1128.2958126434.39427661CS
5211.6956.692531522820.6243.1118.9463831030.15579945CS
156-3.66-10.17514595535.9759.6118.9448729034.09313046CS
260-14.16-30.471271788346.4789.1818.9441576741.52638687CS

ATRC - Frequently Asked Questions (FAQ)

What is the current AtriCure share price?
The current share price of AtriCure is $ 32.31
How many AtriCure shares are in issue?
AtriCure has 49,504,851 shares in issue
What is the market cap of AtriCure?
The market capitalisation of AtriCure is USD 1.6B
What is the 1 year trading range for AtriCure share price?
AtriCure has traded in the range of $ 18.94 to $ 43.11 during the past year
What is the PE ratio of AtriCure?
The price to earnings ratio of AtriCure is -35.78
What is the cash to sales ratio of AtriCure?
The cash to sales ratio of AtriCure is 3.44
What is the reporting currency for AtriCure?
AtriCure reports financial results in USD
What is the latest annual turnover for AtriCure?
The latest annual turnover of AtriCure is USD 465.31M
What is the latest annual profit for AtriCure?
The latest annual profit of AtriCure is USD -44.7M
What is the registered address of AtriCure?
The registered address for AtriCure is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the AtriCure website address?
The website address for AtriCure is www.atricure.com
Which industry sector does AtriCure operate in?
AtriCure operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SLRXSalarius Pharmaceuticals Inc
$ 1.32
(111.17%)
13.42M
VERVVerve Therapeutics Inc
$ 11.35
(81.02%)
1.4M
SAFXXCF Global Inc
$ 3.52
(59.28%)
6.12M
TDTHTrident Digital Tech Holdings Ltd
$ 0.3622
(48.14%)
27.02M
RGCRegencell Bioscience Holdings Ltd
$ 87.20
(45.33%)
225.08k
LDTCLeddarTech Holdings Inc
$ 0.1319
(-36.09%)
418.31k
RUNSunrun Inc
$ 7.03
(-27.07%)
354.11k
GLXGGalaxy Payroll Group Ltd
$ 0.3703
(-23.82%)
977.64k
SDSTStardust Power Inc
$ 0.30
(-22.74%)
139.04k
SEDGSolarEdge Technologies Inc
$ 18.99
(-20.81%)
187.15k
GTIGraphjet Technology
$ 0.0888
(15.93%)
64.53M
TDTHTrident Digital Tech Holdings Ltd
$ 0.3622
(48.14%)
27.02M
GNLNGreenlane Holdings Inc
$ 0.011
(-11.29%)
22.36M
SLRXSalarius Pharmaceuticals Inc
$ 1.32
(111.17%)
13.42M
HCTIHealthcare Triangle Inc
$ 0.0254
(-3.79%)
9.03M

ATRC Discussion

View Posts
mlkrborn mlkrborn 12 years ago
HISTORY
Initial Public Offering



On August 10, 2005, we consummated an initial public offering of 4.6 million shares of our common stock at $12.00 per share, which includes the underwriters exercise of their over-allotment option, on August 9, 2005, to purchase 600,000 shares of our common stock of which 450,000 shares were sold by selling shareholders and 150,000 shares were sold by us. We did not receive any proceeds from the sale of the 450,000 shares of common stock that were sold by selling shareholders. These share amounts reflect a 1-for-3.8 reverse split of our capital stock that was effected on July 27, 2005. Proceeds to us from the offering, after deducting underwriting discounts and commissions but before expenses, were $46.3 million. Expenses are estimated to be approximately $3.25 million.



15
👍️0
mlkrborn mlkrborn 12 years ago
AtriCure receives FDA approval for investigational study to evaluate stroke prevention in atrial fibrillation (ATRC) 14.35 : Co announces the FDA approval to begin enrollment in a clinical study of AtriCure's AtriClip Left Atrial Appendage Exclusion System. The study will evaluate the use of the AtriClip device to prevent stroke in patients with Afib. The feasibility study will enroll Afib patients at seven medical centers across the country. The study will focus on patients with risk factors that place them at significant risk of stroke as well as substantial bleeding risks that contraindicate them for anticoagulation therapy. Research suggests that up to 40% of patients are unable to take oral anticoagulants due to excessive risk of bleeding.
👍️0
dmarkg dmarkg 12 years ago
Hey Wobblenuts and Jackie Scan I want to show you something....

Medical Breakthrough Wound Stasis Technology

ATRC and EPGL could possibly go hand in hand here...
Merry Christmas 2012

Merry Chirstmas 2012, friends.
👍️0
wobblenuts wobblenuts 13 years ago
Any talks involving ATRC and soon to be sub penny wonder EPGL?



Are they hinting at something here?


1)"ATRC fully SEC reporting financials are available at OTCMARKETS for EPGL investors to see as an example of where EPGL management is headed."

2)"EPGL initiating R&D on 4 new medical devices before end of 2012."

3)"Property and equipment, net 0"
👍️0
Penny Roger$ Penny Roger$ 13 years ago
~ Monday! $ATRC ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $ATRC ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=ATRC&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=ATRC&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=ATRC
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ATRC#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ATRC+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ATRC
Finviz: http://finviz.com/quote.ashx?t=ATRC
~ BusyStock: http://busystock.com/i.php?s=ATRC&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ATRC >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 13 years ago
AtriCure, Inc., is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue. Its primary product line, which accounts for a majority of its revenues, is Isolator Synergy bipolar ablation clamp system (Isolator system) and related radiofrequency ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. In addition, it offers the AtriClip Gillinov-Cosgrove Left Atrial Appendage System, or AtriClip system, which is designed to exclude the left atrial appendage.

http://www.google.com/finance?q=ATRC
👍️0

Your Recent History

NASDAQ
ATRC
AtriCure
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads